CRH vs LIN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CRH exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and financial stability. While the current price of $118.00 trades at a significant premium to its Graham Number ($66.71), it remains well below its growth-based intrinsic value of $162.54. The company is outperforming its sector in valuation (P/E 21.42 vs Sector Avg 37.99) and profitability, supported by an impressive 48.4% YoY earnings growth. Despite a bearish technical trend, the strong analyst consensus and healthy balance sheet suggest a compelling long-term value proposition.
LIN shows neutral fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
CRH vs LIN: Head-to-Head Comparison
This page compares CRH plc (CRH) and Linde plc (LIN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.